Overcoming efficacy, safety, and manufacturing hurdles through innovative personalized cancer vaccine design ...
The Chosun Ilbo on MSN
Pet longevity industry advances with anti-aging, obesity treatments
The lifespan of companion animals remains shorter compared to humans. Unlike the rapid advancement in medical technology that ...
Subcutaneous immunotherapy for cancer can cause many of the same side effects as intravenous (IV) immunotherapy because it involves the same medications. Injection site reactions are a common but ...
SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the ...
Patients with non-squamous non-small cell cancer may achieve similar outcomes with a subcutaneous formulation of the immunotherapy toripalimab as with IV administration.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results